When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
TFFP - TFF Pharma's voriconazole inhalation powder shows favorable safety profile in early-stage study
TFF Pharmaceuticals Inc - Ordinary Shares
Topline results from a Phase 1 clinical trial evaluating TFF Pharmaceuticals' (TFFP+3.4%) voriconazole inhalation powder in 64 healthy volunteers showed a favorable safety profile with no signs of clinically significant hepatic oar visual toxicities associated with oral or intravenous formulations.
More news on: TFF Pharmaceuticals, Inc., Healthcare stocks news, Stocks on the move,